CompoAtlas

Nylozan Children - Cough, Bronchitis, Laryngitis and Pharyngitis

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Ulmus rubra

Source : Ulmus rubra - Écorce interne (tige)

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 150 mg

37.5 mgNot calculated
Pelargonium sidoides

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 200 mg

20 mgNot calculated
Thymus vulgaris

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 350 mg

87.5 mgNot calculated

Non-medicinal ingredients

Saveur, Sorbate de potassium, Eau purifiée, Gomme de xanthane, Acide citrique, D-Fructose, Benzoate de sodium

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 6 years ; maximum: 11 years1 Cuillère à café2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to reduce/relieve the symptoms of upper respiratory tract infections (e.g., common colds). Helps to provide(s) symptomatic relief from/reduce(s) symptom severity of bronchitis, laryngitis, pharyngitis, and/or the common cold (in children). Helps to relieve(s) symptoms (of cough, runny nose, sore throat, sputum, and/or chest pain from coughing) associated with bronchitis, laryngitis, pharyngitis, and/or the common cold (in children). Helps to reduce the recovery time from/duration of bronchitis, laryngitis, pharyngitis, and/or the common cold (in children). Helps to reduce/relieve the symptoms associated with bronchitis and upper respiratory tract infections (e.g., common colds). Helps to reduce/relieve the symptoms (cough, runny nose, sore throat, sputum, and/or chest pain from coughing) associated with upper respiratory tract infections (e.g., common colds).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Les laboratoires Nicar inc.
NPN or DIN-HM
80133240
Status
Active licence
Licence date
8 August 2024
Revision date
Not provided
Form
Liquide
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80133240

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Thymus vulgaris
    Read the warning, when it applies and the studies cited

    THYME - THYMUS VULGARIS - Buccal

    Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Health Canada monograph dated 28 March 2025

    THYME - THYMUS VULGARIS - Oral

    Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.

    Health Canada monograph dated 26 June 2026

    THYME - THYMUS VULGARIS - Topical

    Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindications

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Nylozan Children - Cough, Bronchitis, Laryngitis and Pharyngitis”, https://compoatlas.com/en/supplements/canada/80133240-nylozan-children-cough-bronchitis-laryngitis-and-pharyngitis, updated 8 August 2024.

Enter to analyse, Shift+Enter for a new line